Bu‐Chin Yu
-
- Andrographolide Research and Applications 2
- Urology top 10%
-
- PI3K/AKT/mTOR signaling in cancer 3
- Metabolism, Diabetes, and Cancer 3
- Peroxisome Proliferator-Activated Receptors 2
- Mitochondrial Function and Pathology 1
-
- Neuropeptides and Animal Physiology 3
-
- Cancer, Hypoxia, and Metabolism 2
-
- PARP inhibition in cancer therapy 2
Bu‐Chin Yu
14 papers receiving 483 citations
Peers
Comparison fields: 5 of 79
- Complementary and alternative medicine 161
- Endocrinology, Diabetes and Metabolism 96
- Biological Psychiatry 14
- Urology 35
- Pharmacology 40
Countries citing papers authored by Bu‐Chin Yu
This map shows the geographic impact of Bu‐Chin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bu‐Chin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bu‐Chin Yu more than expected).
Fields of papers citing papers by Bu‐Chin Yu
This network shows the impact of papers produced by Bu‐Chin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bu‐Chin Yu. The network helps show where Bu‐Chin Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bu‐Chin Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 8 | |
| 2 | 2016 | 18 | |
| 3 | 2015 | 24 | |
| 4 | 2015 | 37 | |
| 5 | 2014 | 31 | |
| 6 | 2013 | 15 | |
| 7 | 2012 | 41 | |
| 8 | 2012 | 9 | |
| 9 | 2011 | 6 | |
| 10 | 2011 | 26 | |
| 11 | 2010 | 74 | |
| 12 | 2007 | 37 | |
| 13 | 2004 | 16 | |
| 14 | 2003 | 170 |
About Bu‐Chin Yu
Bu‐Chin Yu is a scholar working on Biological Psychiatry, Complementary and alternative medicine, Cellular and Molecular Neuroscience, Urology and Molecular Biology, having authored 14 papers that have together received 512 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), Neuropeptides and Animal Physiology (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Andrographolide Research and Applications (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), PARP inhibition in cancer therapy (2 papers) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Complementary and alternative medicine (161 citations), Endocrinology, Diabetes and Metabolism (96 citations), Biological Psychiatry (14 citations), Urology (35 citations) and Pharmacology (40 citations). Bu‐Chin Yu has collaborated with scholars based in Taiwan, Japan and Hong Kong. Frequent co-authors include Juei‐Tang Cheng, Wang-Chuan Chen, Chen‐Road Hung, Yat-Ching Tong, Chiung-Wen Tsao, Kung-Chia Young, Fumihiko Hakuno, Shin‐Ichiro Takahashi, Chiou‐Feng Lin and Yukio Ando. Their work appears in journals such as Planta Medica, Neurourology and Urodynamics, Scientific Reports, Frontiers in Endocrinology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.